1-3 of 3
David S Viswanatha
Close
Sort by
Journal Articles

Molecular and Clinical Characterization of ETNK1-mutated Myeloid Neoplasms: The Mayo Clinic Experience

Steven Tessier, Rong He, Patricia T. Greipp, David S Viswanatha, Kurt R Bessonen, Terra L Lasho, James M Foran, Cecilia Arana-Yi, Naseema Gangat, Ayalew Tefferi, Mithun Vinod Shah, Hassan B Alkhateeb, Shujun Liu, Animesh D Pardanani, Mrinal M. Patnaik, Aref Al-Kali
Journal: Blood Advances
Blood Adv bloodadvances.2024013255.
https://doi.org/10.1182/bloodadvances.2024013255
Published: 2024
Includes: Supplemental data
Journal Articles

A clinical laboratory–developed LSC17 stemness score assay for rapid risk assessment of patients with acute myeloid leukemia

Stanley W. K. Ng, Tracy Murphy, Ian King, Tong Zhang, Michelle Mah, Zhibin Lu, Natalie Stickle, Narmin Ibrahimova, Andrea Arruda, Amanda Mitchell, Ming Mai, Rong He, Bindu Swapna Madala, David S. Viswanatha, John E. Dick, Steven Chan, Carl Virtanen, Mark D. Minden, Timothy Mercer, Tracy Stockley, Jean C. Y. Wang
Journal: Blood Advances
Blood Adv (2022) 6 (3): 1064–1073.
https://doi.org/10.1182/bloodadvances.2021005741
Published: 2022
Includes: Supplemental data
Journal Articles

Characterization of a cryptic IGH/CCND1 rearrangement in a case of mantle cell lymphoma with negative CCND1 FISH studies

Clinical Trials & Observations
Jess F. Peterson, Linda B. Baughn, Rhett P. Ketterling, Beth A. Pitel, Stephanie A. Smoley, George Vasmatzis, James B. Smadbeck, Patricia T. Greipp, Abhishek A. Mangaonkar, Carrie A. Thompson, Sameer A. Parikh, Dong Chen, David S. Viswanatha
Journal: Blood Advances
Blood Adv (2019) 3 (8): 1298–1302.
https://doi.org/10.1182/bloodadvances.2019031450
Published: 2019
Includes: Supplemental data